Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (666)	5/25/2004 11:24:48 AM
From: tuck	Read Replies (1) \| Respond to of 897

>>Hey tuck, how about a quick short of hollis-eden, the company apparently with a cure for nuclear radiation and other ills.<< In the WatchList. Sorry, for the possibly too slow response. I was in Yosemite, and just got back late yesterday. Saturday headed for Smith Rock in Oregon for a week. Once I get back, more serious research can be done. Until then I can only ask . . . rationale, entry price, target, and time frame, please? If you think it's still in play? Used to follow them a little. Virtual company doing its R&D with academic collaborators. The model seems to work better than it did for BLSI and INCR, but I have my doubts. Radiation cure an immune system stimulator. With the worry about dirty bombs (easier than bioterror?) propping it up. Sheesh, look at VaxGen. Utter clinical failure, but some bioterror work holding it together. I don't see this dynamic disappearing anytime soon, so the results for their "cure" must look questionable to you? What got your attention on it? TIA & Cheers, Tuck